Searchable abstracts of presentations at key conferences in endocrinology

ea0035p1115 | Thyroid Cancer | ECE2014

Preoperative TSH value, does it predict the surgical findings in papillary thyroid cancer?

Paja Miguel , Ciriza Maite Perez de , Calles Laura , Etxeberria Eider , Oleaga Amelia , Lizarraga Aitzol

TSH level has been proposed as a thyroid malignancy predictor in nodular thyroid disease. In addition, several clinical studies have reported that higher preoperative serum TSH levels were associated with more advanced stages of differentiated thyroid cancer (DTC) at the time of diagnosis.Methods: We collected retrospectively preoperative serum TSH from patients diagnosed of papillary thyroid cancer (PTC) who had undergone total thyroidectomy during the ...

ea0035p1118 | Thyroid Cancer | ECE2014

Clinical and biochemical characteristics of papillary thyroid cancer according to the presence of BRAF (V600E) mutation

Oleaga Amelia , Goni Fernando , Ciriza Miguel Paja1, Maite Perez de , Etxeberria Eider , Calles Laura , Ugarte Estibaliz , Ugalde Aitziber , Elorza J Ramon

Introduction: BRAF (V600E) mutation is the most frequent detected genetic change in papillary thyroid cancer (PTC). Its presence has been related to aggressive clinical and pathological features. Therefore, BRAF mutation has drawn considerable interest as a potential prognostic factor for PTC. The presence of the mutation confers the tumour a disability to uptake RAI, diminishing the therapeutic tools. However if this feature is related to some kind of tumour dedifferentiation...